Avandia® Injury Lawyers
Avandia® (rosiglitazone maleate) has been a topic of controversy for some time now. The U.S. Food and Drug administration (FDA) met in 2010 to discuss whether the risks outweighed the benefits. The agency decided to restrict access of the drug in September 2010, only making it available to certain patients who cannot take other medications to treat their diabetes, and those who are already taking the medicine. The drug has been banned in Europe.
GlaxoSmithKline is also required to maintain a Risk Evaluation and Mitigation Strategy (REMS). REMS is program aimed at controlling safe use of the medicine. The program has not yet been implemented, according to reports. Avandia® sales have plummeted since it came out that it might be linked to an increased risk of heart failure in some patients. A total of 13.3 million prescriptions were written for Avandia® in 2006. This number dropped to 2.6 million in 2009 and dropped another 29 percent by June 2010, according to reports.
Patients and healthcare providers have been warned of the potential health risks associated with Avandia®, including heart attack, stroke and congestive heart failure.
If you’re among the millions of diabetic patients who has been prescribed Avandia® and has suffered a heart attack, stroke or other ill condition, contact an Avandia® injury lawyer to find out if you qualify for compensation. Send us an email or call (800) 722-0513 and schedule an evaluation of your case.